Tykhe Corp

PINK:HALB USA Biotechnology
Market Cap
$1.49 Million
Market Cap Rank
#50626 Global
#15479 in USA
Share Price
$0.00
Change (1 day)
-4.55%
52-Week Range
$0.00 - $0.00
All Time High
$0.08
About

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Tykhe Corp (HALB) - Total Liabilities

Latest total liabilities as of October 2025: $854.03K USD

Based on the latest financial reports, Tykhe Corp (HALB) has total liabilities worth $854.03K USD as of October 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Tykhe Corp - Total Liabilities Trend (2008–2025)

This chart illustrates how Tykhe Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Tykhe Corp Competitors by Total Liabilities

The table below lists competitors of Tykhe Corp ranked by their total liabilities.

Company Country Total Liabilities
Paragon Shipping Inc
PINK:PRGNF
USA $19.30 Million
Topcon Corporation
PINK:TOPCF
USA $1.09 Billion
Kings Arms Yard Vct Plc
LSE:KAY
UK GBX12.61 Million
Australian Oil & Gas Corporation
PINK:AOGC
USA $1.03 Million
GAS2GRID
BE:GT4
Germany €6.20 Million
Buyer Group International Inc
PINK:BYRG
USA $24.80K

Liability Composition Analysis (2008–2025)

This chart breaks down Tykhe Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.00 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.01 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 198.47 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tykhe Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tykhe Corp (2008–2025)

The table below shows the annual total liabilities of Tykhe Corp from 2008 to 2025.

Year Total Liabilities Change
2025-07-31 $917.60K +25.92%
2024-07-31 $728.72K -22.36%
2023-07-31 $938.65K +25.99%
2022-07-31 $745.01K +35.77%
2021-07-31 $548.71K +89.66%
2020-07-31 $289.31K -38.44%
2019-07-31 $469.95K -54.90%
2017-07-31 $1.04 Million -15.13%
2016-07-31 $1.23 Million +124.14%
2011-07-31 $547.75K -44.12%
2010-07-31 $980.19K +36.95%
2009-07-31 $715.75K +89.45%
2008-07-31 $377.80K --